Supplemental Material to

24 downloads 0 Views 431KB Size Report
Supplemental Figure S1: Mitochondrial membrane potential remains unaffected by silencing of. MCU, UCP2/3 or Letm1. HeLa cells were co-transfected with the ...
Supplemental Material to

Molecularly distinct routes of mitochondrial Ca2+ uptake are activated depending on the activity of the sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) Markus Waldeck-Weiermair1, András T. Deak1, Lukas N. Groschner, Muhammad Rizwan Alam, Claire Jean-Quartier, Roland Malli and Wolfgang F. Graier* Institute of Molecular Biology and Biochemistry, Center of Molecular Medicine, Medical University of Graz, 8010-Graz, Austria

Supplemental Figure S1: Mitochondrial membrane potential remains unaffected by silencing of MCU, UCP2/3 or Letm1 HeLa cells were co-transfected with the respective siRNAs and a plasmid encoding for nuclear localization signal-green fluorescent protein in order to allow identification of transfected cells in subsequent experiments. 48 h after transfection cells were loaded with 200 nM tetramethylrhodamine methyl ester (TMRM) for 30 min at room temperature. Experiments were carried out in quench mode as described recently (1). TMRM fluorescence of single cells was recorded and normalized to peak fluorescence intensities during depolarization of ΔΨmito with 2 µM of the protonophore carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP). Mitochondrial inner membrane potential was determined by measuring TMRM fluorescence after application of siRNAs targeting MCU (n=77), UCP2/3 (n=64), Letm1 (n=79) or a combination of siRNAs targeting both MCU and UCP2/3 (n=72) or MCU and Letm1 (n=79). Cells transfected with scrambled siRNA were used as a control (n=80). Silencing of MCU, UCP2/3 or Letm1 did not alter mitochondrial membrane potential and neither did the combined knock-down of MCU and UCP2/3 or that of MCU and Letm1. Supplemental Figure S2: Mitochondrial Ca2+ extrusion is not affected by the siRNA mediated knockdown of MCU, Letm1, UCP2/3 or MCU in a combination with Letm1 or UCP2/3 HeLa cells were co-transfected with the mitochondrial Ca2+ sensor 4mtD1GO-Cam and siRNAs against MCU (siMCU), Letm1 (siLetm1), UCP2/3 (siUCP2/3) or a combination of MCU together with either UCP2/3 (siUCP2/3 + siMCU) or Letm1 (siLetm1 + siMCU). Mitochondrial Ca2+ was measured under nominal Ca2+ free condition upon stimulation with 100 µM histamine in the absence (A-E, K) or presence of 1µM thapsigargin (F-J, L). Mitochondrial Ca2+ efflux capacity was determined by the slope of the decrease of normalized 4mtD1GO-Cam signals. The drop kinetic of normalized ratio signals starting either at 1.03 (histamine stimulation alone) or at 1.04 (in the presence of thapsigargin) under each individual condition was analyzed over a time period of 20 seconds using linear regression. Cells transfected with a scrambled siRNA were used as Control (Control, grey curves and black regression lines) under both conditions, in the absence (n=18, A-E) or presence (n=15, F-J) of thapsigargin. (A) siUCP2/3 (green curve and regression line, n=8); (B) siMCU (orange curve and regression line, n=13), (C) siLetm1 (brown curve and regression line, n=11), (D) siLetm1 + siMCU (violet curve and regression line, n=11), (E) siUCP2/3 + siMCU (dark red curve and regression line, n=7), (F) siUCP2/3 (n=13), (G) siMCU (n=15), (H) siLetm1 (n=11), (I) siLetm1 + siMCU (n=7), (J) siMCU + siUCP2/3 (n=6). (K, L) Respective initial normalized 4mtD1GO-Cam ratio values (1.03 in the absence of thapsigargin and 1.04 in the presence of thapsigargin) were defined as 100 % and the average slopes of the linear regressions were calculated and plotted as percentage per second (%/s).

Supplemental Figure S3: Double knock-down of either MCU and UCP2/3 or MCU together with Letm1 did not further reduce [Ca2+]mito HeLa cells were transfected with a scrambled siRNA (Control, black curves) or siRNA against MCU (siMCU, orange curves) alone or in combination with either siRNA against Letm1 (siLetm1 + siMCU, violet curves) or UCP2/3 (siUCP2/3 + siMCU, dark red curves) together with a plasmid encoding for 4mtD1GO-Cam. (A) Cells were stimulated with 100 µM histamine in a nominal Ca2+ free solution and simultaneously recorded for mitochondrial (left panel) or cytosolic Ca2+ (right panel). Average curves of Control (n=21) were compared with that of siMCU (n=17), siLetm1 + siMCU (n=18) or siUCP2/3 + siMCU (n=27). *, p < 0.05 vs. Control [Ca2+]mito. (B) Cells were stimulated with histamine in the presence of thapsigargin and mitochondrial (left panel) and cytosolic Ca2+ (right panel) were simultaneously measured. Statistical analysis was performed for siMCU (n=20), siLetm + siMCU (n=14) and siUCP2/3 + siMCU (n=14) versus Control (n=19). *, p < 0.05 vs. Control [Ca2+]mito.

References: 1 Deak AT, Groschner LN, Alam MR, Seles E, Bondarenko AI, Graier WF, Malli R. (2012) The endocannabinoid N-arachidonoyl glycine (NAGly) inhibits store-operated Ca2+ entry by abrogating STIM1/Orai1 interaction. Journal of Cell Science 2013 (in press) doi: 10.1242/jcs.118075

U

C

M

si

U

C

iM

+s

1

C U

tm

si Le

+

1

/3

P2

U C

si

tm

Le

si

M

si

l

/3

P2

U C

si

tro

on

C

TMRM (F FCCP /F0)

Supplemental Figure S1

Dy mito 1.4 1.2

1.0

0.8

0.6

0.4

0.2

0.0

Supplemental Figure S2

1.018

Histamine + Thapsigargin

1.025

10 15 Time (s)

20

0.0

Ratio (F560/F510)/F0

J

1.035

1.030

0

- Tg

5

10 15 Time (s)

Control siLetm1 + siMCU 0

L

5

10 15 Time (s)

U

M C

M C

si

si

+ /3

-2.5

P2

-2.5

U

-1.5 -2.0

Control siUCP2/3 + siMCU 0

-1.0

-2.0

1.030

+ Tg

C

Slope (%/s)

-1.5

1.035

20

-0.5

-1.0

20

1.040

1.020

0.0

-0.5

10 15 Time (s)

1.025

1.020 20

5

Histamine + Thapsigargin

[Ca2+]mito

1

5

Control siUCP2/3 + siMCU 0

1.025 Control siLetm1

1.020

20

1.040

+

0

K

1.030

10 15 Time (s)

m 1

20

si si Le Le tm tm + si U si C M P2 C U /3 + si M C U

10 15 Time (s)

1.035

1.020

U

5

Control siMCU

M C

0

[Ca2+]mito

1.022

1.014

Histamine + Thapsigargin

1.025

1.020

Slope (%/s)

1.020

I

5

si U

Control siUCP2/3

1.040

0

si Le tm

1.025

1.030

20

Le t

1.030

1.014

Histamine + Thapsigargin

[Ca2+]mito

1.035

10 15 Time (s)

1.024

1.016

Control siLetm1 + siMCU

si

Ratio (F 560 /F510 )/F0

1.035

1.040

H

5

Histamine

1.018

C U

[Ca2+]mito

0

20

1.020

1.016

Control siLetm1

1.014 10 15 Time (s)

1.022

si M

1.040

G

5

1.024

/3

Histamine + Thapsigargin

0

1.026

1.018

1.016

Control siMCU

1.014 20

1.020

1.026

P2

10 15 Time (s)

1.022

1.030 1.028

U C

5

1.024

[Ca2+]mito

Ratio (F 560 /F510 )/F0

1.020

Ratio (F 560 /F510 )/F0

0

Ratio (F 560 /F510 )/F0

1.022

1.016

Control siUCP2/3

1.014

[Ca2+]mito

1.024

1.018

1.016

F

1.026

E

Histamine

1.028

si

1.018

1.026

[Ca2+]mito

Ratio (F560/F510)/F0

1.020

1.028

1.030

Ratio (F 560 /F510 )/F0

1.022

1.028

D

Histamine

ro l

1.024

[Ca2+]mito

1.030

on t

1.026

Ratio (F560/F510)/F0

Ratio (F560/F510)/F0

1.028

C

Histamine

C

[Ca2+]mito

1.030

Ratio (F560/F510)/F0

B

Histamine

si

[Ca2+]mito

1.030

C on tro l si U C P2 /3

A

5

10 15 Time (s)

20

Supplemental Figure S3 A

Histamine

Histamine 2.4

Control siMCU siLetm1 + siMCU siUCP2/3 + siMCU

1.10 [Ca2+]mito

[Ca2+]cyto 2.2

Ratio(F 340/F380)/R0

Ratio(F 560/F510)/F0

1.08 1.06 1.04

Control siMCU siLetm1 + siMCU siUCP2/3 + siMCU

*'*'*

2.0 1.8 1.6 1.4

1.02 1.2 1.00

1.0 1.0

1.5

B

2.0 Time(min)

2.5

1.0

3.0

Thapsigargin

2.4

Control siMCU siLetm1 + siMCU siUCP2/3 + siMCU

[Ca2+]mito

Ratio(F 340/F380)/R0

Ratio(F 560/F510)/F0

2.5

3.0

Control siMCU siLetm1 + siMCU siUCP2/3 + siMCU

[Ca2+]cyto 2.2

1.08

*'*'*

1.06

2.0 Time(min)

Thapsigargin Histamine

Histamine 1.10

1.5

1.04

2.0 1.8 1.6 1.4

1.02 1.2 1.00

1.0 1.0

1.5

2.0 Time(min)

2.5

3.0

1.0

1.5

2.0 Time(min)

2.5

3.0